These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4589794)

  • 1. Haemodynamic effects of beta-receptor blocking agents and digitalis in ischaemic coronary heart disease with angina pectoris.
    Dunér H; Pernow B
    Acta Med Scand; 1973 Dec; 194(6):517-23. PubMed ID: 4589794
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of the effect of LB-46 and propranolol on central haemodynamic in cases with angina pectoris.
    Duner H; Pernow B
    Indian Heart J; 1972 Jun; 24():Suppl 1:180-2. PubMed ID: 4667014
    [No Abstract]   [Full Text] [Related]  

  • 3. Propranolol and LB 46 (prinodolol) in angina pectoris. A comparative long-term ergometric study.
    Arstila M; Kallio V; Wendelin H
    Ann Clin Res; 1973 Apr; 5(2):91-100. PubMed ID: 4201295
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemodynamic effects of beta-adrenergic blockade.
    Aström H
    Br Heart J; 1968 Jan; 30(1):44-9. PubMed ID: 5637556
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta adrenergic blockade. Hemodynamics and myocardial energy metabolism in patients with ischemic heart disease.
    Lewis CM; Brink AJ
    Am J Cardiol; 1968 Jun; 21(6):846-59. PubMed ID: 5678218
    [No Abstract]   [Full Text] [Related]  

  • 6. Preservation of ischemic myocardium.
    Forrester JS; Chatterjee K
    Adv Cardiol; 1974; 11(00):158-0. PubMed ID: 4415185
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of alprenolol on hemodynamics in angina pectoris.
    Cullhed I
    Acta Med Scand; 1973 May; 193(5):411-8. PubMed ID: 4717322
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical management of patients with angina pectoris.
    Goldstein RE; Epstein SE
    Prog Cardiovasc Dis; 1972 Jan; 14(4):360-98. PubMed ID: 4400516
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of angina pectoris. Therapeutic methods and physiologic mechanisms.
    Amsterdam EA; Hughes JL; Miller RR; Massumi RA; Zelis R; Mason DT
    Adv Cardiol; 1974; 11(00):175-90. PubMed ID: 4213235
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Prichard BN
    Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris.
    Heterington DJ; Comerford MB; Nyberg G; Besterman EM
    Br Heart J; 1973 Mar; 35(3):320-33. PubMed ID: 4632566
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.
    Aström H; Vallin H
    Br Heart J; 1974 Dec; 36(12):1194-1200. PubMed ID: 4155316
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease.
    Silke B; Nelson GI; Ahuja RC; Okoli RC; Taylor SH
    Eur J Clin Pharmacol; 1983; 25(2):157-65. PubMed ID: 6628498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina.
    Aronow WS; March H; Vangrow JS; Cassidy J; Kern JC; Khemka M; Vawter M; Pagano J
    Br Heart J; 1974 Nov; 36(11):1078-81. PubMed ID: 4155953
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic differences in the effects of mepindolol-sulfate and propranolol after 4 weeks treatment under conditions of rest and physical exercise in patients with coronary heart disease (author's transl)].
    Bonelli J; Magometschnigg D; Hitzenberger G; Kaik G
    Z Kardiol; 1978 Jan; 67(1):46-50. PubMed ID: 629073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, electrocardiographic, and haemodynamic effects of digitalis (ouabain) in angina pectoris.
    Sharma B; Majid PA; Meeran MK; Whitaker W; Taylor SH
    Br Heart J; 1972 Jun; 34(6):631-7. PubMed ID: 4402698
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of beta-adrenergic blockade (propranolol) on left ventricular hemodynamics and the electrocardiogram during exercise-induced angina pectoris.
    Dwyer EM; Wiener L; Cox JW
    Circulation; 1968 Aug; 38(2):250-60. PubMed ID: 5666841
    [No Abstract]   [Full Text] [Related]  

  • 18. Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography.
    Manyari DE; Kostuk WJ; Carruthers SG; Johnston DJ; Purves P
    Am J Cardiol; 1983 Feb; 51(3):427-33. PubMed ID: 6401908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the acute haemodynamic effects of propranolol and pindolol at rest and during supine exercise in man.
    Svendsen TL; Carlsen JE; Hartling O; McNair A; Trap-Jensen J
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():465s-468s. PubMed ID: 7449300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Load insufficiency of the heart due to beta receptor blocking agents].
    Froer KL; König E; Grünberg G
    Med Klin; 1969 Sep; 64(37):1663-8. PubMed ID: 4390887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.